All News
Alex Felix has won CURE Epilepsy’s Taking Flight Award to advance his work on “Fine-tuning the 3’UTR as a novel therapeutic strategy for genetic Developmental and Epileptic Encephalopathies.”
Charlene Son Rigby, President and Co-founder of the STXBP1 Foundation, interviews ENDD’s Mike Boland about STXBP1 therapeutic development updates from the annual meeting of the American Society for Gene and Cell Therapy.
From The Transmitter, by Lydia Denworth.
A handful of scientists are committed to advancing research on the autism-related genetic conditions their own children have.
In this piece in Current Problems in Pediatric and Adolescent Health Care, “Accelerating therapeutic development and clinical trial readiness for STXBP1 and SYNGAP1 disorders,”
